Effects of growth hormone therapy on cardiac dimensions in children and adolescents with prader-willi syndrome

Hormone Research in Paediatrics

Volumn 75, Issue 1, 2011, Pages 56-62

  Hauffa, Berthold P ^a,b   Knaup, Kathrin ^a   Lehmann, Nils ^b   Neudorf, Ulrich ^a   Nagel, Bert ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Body mass index; Echocardiography; Growth; IGF I; IGFBP 3

Indexed keywords

GROWTH HORMONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE DEFICIENCY; HEART FUNCTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE; HEART SIZE; HORMONAL THERAPY; HUMAN; INFANT; MALE; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THERAPY EFFECT;

ADOLESCENT; BODY MASS INDEX; CARDIAC VOLUME; CHILD; DRUG MONITORING; DWARFISM, PITUITARY; ECHOCARDIOGRAPHY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; PRADER-WILLI SYNDROME; RETROSPECTIVE STUDIES;

EID: 79151480433     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000319612     Document Type: Article

References (29)

1. Sacca L, Cittadini A, Fazio S: Growth hormone and the heart. Endocr Rev 1994; 15: 555-573.
2. Burman P, Ritzen EM, Lindgren AC: Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 2001; 22: 787-799.
3. Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB: Long-term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi syndrome. J Clin Endocrinol Metab 2010; 95: 1131-1136.
4. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H: Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001; 38: 792-798.
5. Tauber M, Diene G, Molinas C, Hebert M: Review of 64 cases of death in children with Prader-Willi syndrome. Am J Med Genet A 2008; 146: 881-887.
6. Grugni G, Crino A, Bosio L, Corrias A, Cuttini M, De Toni T, Di Batista E, Franzese A, Gargantini L, Greggio N, Iughetti L, Livieri C, Naselli A, Pagano C, Pozzan G, Ragusa L, Salvatoni A, Trifiro G, Beccaria L, Bellizzi M, Bellone J, Brunani A, Cappa M, Caselli G, Cerioni V, Delvecchio M, Giardino D, Ianni F, Memo L, Pilotta A, Pomara C, Radetti G, Sacco M, Sanzari A, Sartorio A, Tonini G, Vettor R, Zaglia F, Chiumello G: The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Am J Med Genet A 2008; 146: 861-872.
7. Alexander RC, Greenswag LR: Medical and nursing interventions; in Greenswag LR, Alexander RC (eds): Management of Prader- Willi Syndrome. Berlin, Springer, 1995, pp 66-80.
8. Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T: Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol 2002; 44: 248-255.
9. Rabkin SW, Chen Y, Leiter L, Liu L, Reeder BA: Risk factor correlates of body mass index. Canadian Heart Health Surveys Research Group. CMAJ 1997; 157(suppl 1):S26-S31.
10. Roelandt J, Gibson DG: Recommendations for standardization of measurements from M-mode echocardiograms. Eur Heart J 1980; 1: 375-378.
11. Reinken L, van Oost G: Longitudinale Körperentwicklung gesunder Kinder von 0 bis 18 Jahren. Klin Pädiatr 1992; 204: 129-133.
12. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiss HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J: Perzentile für den Body-Mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807-818.
13. Blum WF, Breier BH: Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994; 4(suppl 1):11-19.
14. Kampmann C, Wiethoff CM, Wenzel A, Stolz G, Betancor M, Wippermann CF, Huth RG, Habermehl P, Knuf M, Emschermann T, Stopfkuchen H: Normal values of M-mode echocardiographic measurements of more than 2,000 healthy infants and children in central Europe. Heart 2000; 83: 667-672.
15. SAS System. Release 8.2 Edition. Carey/NC, SAS Institute, 2002.
16. Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R: Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone- deficient adolescents. J Clin Endocrinol Metab 2001; 86: 1061-1065.
17. Salerno M, Esposito V, Farina V, Radetti G, Umbaldo A, Capalbo D, Spinelli L, Muzzica S, Lombardi G, Colao A: Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study. J Clin Endocrinol Metab 2006; 91: 1288-1295.
18. Capalbo D, Lo VA, Farina V, Spinelli L, Palladino A, Tiano C, Lettiero T, Lombardi G, Colao A, Salerno M: Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two years prospective, case-control study. J Clin Endocrinol Metab 2009; 94: 3347-3355.
19. Heuschmann D, Butenandt O, Vogel M: Left ventricular volume and mass in children on growth hormone therapy compared with untreated children. Eur J Pediatr 1996; 155: 77-80.
20. Szczepanska-Kostro J, Tolwinska J, Urban M, Gardziejczyk M, Glowinska B: Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency. J Pediatr Endocrinol Metab 2004; 17: 1405-1413.
21. Patel S, Harmer JA, Loughnan G, Skilton MR, Steinbeck K, Celermajer DS: Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clin Endocrinol (Oxf) 2007; 66: 771-777.
22. Marzullo P, Marcassa C, Campini R, Eleuteri E, Minocci A, Priano L, Temporelli P, Sartorio A, Vettor R, Liuzzi A, Grugni G: The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome. J Clin Endocrinol Metab 2005; 90: 5639-5646.
23. Shulman DI, Root AW, Diamond FB, Bercu BB, Martinez R, Boucek RJ Jr: Effects of one year of recombinant human growth hormone therapy on cardiac mass and function in children with classical growth hormone deficiency. J Clin Endocrinol Metab 2003; 88: 4095-4099.
24. Marzullo P, Marcassa C, Campini R, Eleuteri E, Minocci A, Sartorio A, Vettor R, Liuzzi A, Grugni G: Conditional cardiovascular response to growth hormone therapy in adult patients with Prader-Willi syndrome. J Clin Endocrinol Metab 2007; 92: 1364-1371.
25. Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson WK, Ranke MB, Price DA: Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf) 2006; 65: 178-185.
26. Bakker B, Maneatis T, Lippe B: Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005; 63: 33-39). Horm Res 2007; 67: 203-204.
27. Nagai T, Obata K, Tonoki H, Temma S, Murakami N, Katada Y, Yoshino A, Sakazume S, Takahashi E, Sakuta R, Niikawa N: Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005; 136: 45-48.
28. Pomara C, D'Errico S, Riezzo I, de Cillis GP, Fineschi V: Sudden cardiac death in a child affected by Prader-Willi syndrome. Int J Legal Med 2005; 119: 153-157.
29. Ahmad MU, Choy YS, Hung LC, Tan SK, Malinee T, Tan SK, Lim PCK, Othman A, Tan SK, Khoo TB: Dilated cardiomyopathy in two infants with Prader-Willy syndrome and cytogenetically visible microdeletion of 15q11-14. Am J Hum Genet 2001; 69 (suppl):282.